|
PharmaMar's novel ADC demonstrates anticancer activity in HER2-expressing
PharmaMar (MSE:PHM), a world-leading biopharmaceutical company in the discovery and development of innovative marine-derived anticancer drugs, has announced that its novel Antibody-Drug Conjugate...
More... |
| All times are GMT -7. The time now is 10:23 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021